Daria B Crittenden

Summary

Affiliation: New York University School of Medicine
Country: USA

Publications

  1. pmc Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout
    Daria B Crittenden
    Crystal Diseases Study Group, Division of Rheumatology, New York University School of Medicine, New York, New York 10003, USA
    J Rheumatol 39:1458-64. 2012
  2. doi request reprint New therapies for gout
    Daria B Crittenden
    Crystal Diseases Study Group, Division of Rheumatology, Department of Medicine, NYU School of Medicine NYU Langone Medical Center, New York, New York 10003, USA
    Annu Rev Med 64:325-37. 2013
  3. doi request reprint Prevalence of contraindications and prescription of pharmacologic therapies for gout
    Robert T Keenan
    Section of Rheumatology of the New York Harbor Health Care System, New York Campus of the US Department of Veterans Affairs, New York, USA
    Am J Med 124:155-63. 2011
  4. ncbi request reprint The year in gout: 2011-2012
    Daria B Crittenden
    Division of Rheumatology, NYU Hospital for Joint Diseases, New York, NY 10003, USA
    Bull NYU Hosp Jt Dis 70:145-51. 2012
  5. ncbi request reprint The year in gout - 2010-2011
    Daria B Crittenden
    Rheumatology Section, New York Harbor VA Healthcare System New York Campus, New York, New York, USA
    Bull NYU Hosp Jt Dis 69:257-63. 2011

Detail Information

Publications5

  1. pmc Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout
    Daria B Crittenden
    Crystal Diseases Study Group, Division of Rheumatology, New York University School of Medicine, New York, New York 10003, USA
    J Rheumatol 39:1458-64. 2012
    ..We examined whether colchicine use was associated with a reduced risk of myocardial infarction (MI) in patients with gout...
  2. doi request reprint New therapies for gout
    Daria B Crittenden
    Crystal Diseases Study Group, Division of Rheumatology, Department of Medicine, NYU School of Medicine NYU Langone Medical Center, New York, New York 10003, USA
    Annu Rev Med 64:325-37. 2013
    ..These new treatments do not obviate the need for lifestyle and dietary management, another area in which significant scientific and clinical progress has recently been made...
  3. doi request reprint Prevalence of contraindications and prescription of pharmacologic therapies for gout
    Robert T Keenan
    Section of Rheumatology of the New York Harbor Health Care System, New York Campus of the US Department of Veterans Affairs, New York, USA
    Am J Med 124:155-63. 2011
    ..Patients with gout have comorbidities, but the impact of these comorbidities on treatment has not been studied...
  4. ncbi request reprint The year in gout: 2011-2012
    Daria B Crittenden
    Division of Rheumatology, NYU Hospital for Joint Diseases, New York, NY 10003, USA
    Bull NYU Hosp Jt Dis 70:145-51. 2012
    ..Here we review some of the most important recent advances in gout over the past 12 to 18 months...
  5. ncbi request reprint The year in gout - 2010-2011
    Daria B Crittenden
    Rheumatology Section, New York Harbor VA Healthcare System New York Campus, New York, New York, USA
    Bull NYU Hosp Jt Dis 69:257-63. 2011
    ....